跳至主要内容
临床试验/RBR-2mg3xw
RBR-2mg3xw已完成未知

Clinical efficacy of oral and topical treatments based on olive oil extract titrated in hydroxytyrosol to melasma control

Faculdade de Ciências Farmacêuticas de Riberão Preto - USP0 个研究点开始时间: 2019年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
30Y 至 50Y(—)
性别
Female

入选标准

  • 30 to 50 years old; phototype III and IV (Fitzpatrick, 1998); facial hyperpigmentations patterns.

排除标准

  • hyperpigmentations not diagnosed as melasma in the malar region; pregnancy or breastfeeding; individuals with a history of adverse reactions with the use of cosmetic products; individuals in the use of drugs capable of producing an abnormal skin response; cosmetic and dermo-cosmetic whitening treatments, superficial chemical peels and laser for less than 3 months; use of oral antioxidant supplementation for less than 3 months; localized or generalized dermatological diseases; excess hair on face.

研究者

发起方
Faculdade de Ciências Farmacêuticas de Riberão Preto - USP

相似试验